Zeki at 02:09, 4 November 2024

2024-11-04T02:09:18Z

← Older revision		Revision as of 22:09, 3 November 2024
Line 5:		Line 5:
	'''Drug class: [[:Category: Dopaminergic Antiparkinsonian agent \| Dopaminergic Antiparkinsonian Agent]]'''		'''Drug class: [[:Category: Dopaminergic Antiparkinsonian agent \| Dopaminergic Antiparkinsonian Agent]]'''

	'''Ropinirole'''（中文：[[羅匹尼羅]]） is a non-ergoline dopamine agonist primarily used to treat Parkinson's disease and Restless Legs Syndrome (RLS). It mimics the action of dopamine, a neurotransmitter that plays a crucial role in movement and coordination.		'''Ropinirole (REQUIP)'''（中文：[[羅匹尼羅]]） is a non-ergoline dopamine agonist primarily used to treat Parkinson's disease and Restless Legs Syndrome (RLS). It mimics the action of dopamine, a neurotransmitter that plays a crucial role in movement and coordination.
	==Common Strengths==		==Common Strengths==
	*Immediate Release Tablets: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 5 mg		*Immediate Release Tablets: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 5 mg

Zeki: Created page with "Category: DrugsCategory: Dopaminergic Antiparkinsonian agent '''Antiparkinsonian Drug''' '''Drug class: :Category: Dopaminer..."

2024-11-04T01:12:25Z

Created page with "Category: Drugs Category: Dopaminergic Antiparkinsonian agent '''Antiparkinsonian Drug''' '''Drug class: :Category: Dopaminer..."

New page

[[Category: Drugs]][[Category: Dopaminergic Antiparkinsonian agent]]

[[:Category: Antiparkinsonian Drug | '''Antiparkinsonian Drug''']]

'''Drug class: [[:Category: Dopaminergic Antiparkinsonian agent | Dopaminergic Antiparkinsonian Agent]]'''

'''Ropinirole'''（中文：[[羅匹尼羅]]） is a non-ergoline dopamine agonist primarily used to treat Parkinson's disease and Restless Legs Syndrome (RLS). It mimics the action of dopamine, a neurotransmitter that plays a crucial role in movement and coordination.
==Common Strengths==
*Immediate Release Tablets: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 5 mg
*Extended Release Tablets: 2 mg, 4 mg, 6 mg, 8 mg, 12 mg

==Drug Trade Names==
*Requip
*Requip XL

==Drug Usage==
Ropinirole is indicated for:
*Parkinson's Disease: To alleviate symptoms such as stiffness and tremors.
*Restless Legs Syndrome (RLS): To reduce the urge to move the legs.

==Mechanism of Action==
Ropinirole selectively stimulates dopamine D2 receptor in the brain, which is involved in movement control. It works by mimicking the action of dopamine, a neurotransmitter deficient in individuals with Parkinson's disease, helping improve motor control and reduce symptoms such as stiffness, tremors, and muscle spasms.

==Route of Administration==
Oral

==Dosages==
*Starting at 0.25 mg three time daily for Parkinson's; can be increased up to a maximum of 24 mg/day for patients not on levodopa.

Restless Legs Syndrome:
*Initial Dose: Begins at 0.25 mg once daily, taken 1-3 hours before bedtime.
*Maximum Dose: Generally capped at 4 mg per day.

==Side Effects==
{| class="wikitable"
!style="text-align: left"| Frequency
!Adverse reactions
|-
| rowspan="3" | '''Common Side Effects
| Drowsiness
|-
| Dizziness
|-
| Nausea
|-
| rowspan="5" | '''Serious Side Effects
| Sudden sleep episodes
|-
| Hallucinations
|-
| Severe drowsiness or confusion
|-
| Orthostatic hypotension
|-
| Dyskinesias (involuntary movements)
|}

==Pharmacokinetics==
*Ropinirole is primarily metabolized in the liver
*Half-life: 5-6 hours
*Onset Time: Typically, within several weeks for symptom improvement
*Duration of Action: Varies based on formulation (immediate vs extended release)

==Drug Precautions==
'''Pregnancy

Category C; potential risks should be discussed with a healthcare provider.

'''Breastfeeding

Not known if it passes into breast milk; may affect milk production.

'''Children and Elderly

Not approved for use in children under 18; caution advised in elderly due to increased risk of side effects.

'''Drug Monitoring Items
*Patients should be monitored for signs of orthostatic hypotension, particularly during dose escalations
*Withdrawal Symptoms

Gradual tapering is advised when discontinuing ropinirole to avoid withdrawal symptoms such as fever, confusion, or severe muscle stiffness. A typical tapering schedule involves reducing the dose over a week.

'''Drug Interactions

May interact with medications affecting dopamine levels, such as:
*Antidepressants: e.g. Duloxetine (Cymbalta), Fluvoxamine (Luvox)
*Antipsychotics: e.g. Haloperidol, Olanzapine
*Pain medications: Tramadol
*Other medications: e.g. Ciprofloxacin (a fluoroquinolone antibiotic), Metoclopramide (used for nausea).

==FAQ==
'''How Should I Take the Tablet?

Take orally with or without food; follow prescribed dosing schedule.

'''What Should I Avoid While Taking?

Avoid alcohol and activities requiring alertness until you know how Ropinirole affects you.

'''What Happens if I Miss a Dose?

Take it as soon as you remember unless it is almost time for the next dose; do not double up on doses.

Ropinirole - Revision history

Zeki at 02:09, 4 November 2024

Zeki: Created page with "Category: DrugsCategory: Dopaminergic Antiparkinsonian agent '''Antiparkinsonian Drug''' '''Drug class: :Category: Dopaminer..."